Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
Management group
Schroder Investment Management
Launch date
06/05/1994
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2025 AGM.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
248.73 309.14 654.00 739.97 -11.62 6 4.31 Jul, Dec 1.4 (31/08/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
21/12/2023 26/01/2024 13.900 No 2024
27/07/2023 25/08/2023 14.200 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
International Biotechnology Share price total return 4.4 -0.1 28.8 220.7
Biotechnology & Healthcare AIC sector Share price total return 4.5 -20.1 4.7 125.5
Scroll

Share structure

Number of shares
38,032,407

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 45,126 1,323,281 12,794,083 83,199,765
Average N/A 60,620 50,652 65,935
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.30 8.85 81.77 571.85
Average N/A 0.40 0.32 0.45
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB0004559349 IBT GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 29/02/2024

Investment % of total assets
Cytokinetics Inc 5.2
Sv Fund Vi Investment 4.8
Supernus Pharmaceuticals Inc 4.6
Gilead Sciences Inc 4.3
Biomarin Pharmaceutical Inc 4.2
Vera Therapeutics Inc Class A 4.2
United Therapeutics Corp 3.9
Incyte Corp 3.7
Amgen Inc 3.5
Scb Sholo211123b 20-Feb-2024 6.4600% 20-Mar-2024 -10.0

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.